Quotes: US MENA   Enter Symbol: NewsLetter: Search: advanced

US- Pfizer to slash 20% of sales workforce: Report  Join our daily free Newsletter

MENAFN - 19/12/2012

No. of Ratings : 0
Add to Mixx!


 


(MENAFN) Pharmaceutical firm Pfizer Inc plans to slash nearly 20 percent of its sales workforce at the primary-care drugs division, reported Reuters citing Bloomberg News report.

The company's spokesman, MacKay Jimeson, who didn't confirm the number of the job cuts, said that Pfizer is making adjustments in several segments of its field force to match the future requirements of the business.

According to the Bloomberg report, the measure, which will start this month, will see nearly 600 out of 3,000 sales staff discharged of their jobs.

It is worth noting that in last year's November, Pfizer, which is reducing costs as cheaper generic drugs have entered the market and eroded market share and revenue, lost its patent in the US for Lipitor, whose annual sales exceeded USD10 billion.

 






  MENA News Headlines


 






Google

 
 

Middle East North Africa - Financial Network

MENAFN News Market Data Countries Tools Section  
 

Middle East North Africa - Financial Network
Arabic MENAFN

Main News
News By Industry
News By Country
Marketwatch News
UPI News
Comtex News

IPO News
Islamic Finance News
Private Equity News

How-To Guides
Technology Section

Travel Section

Search News

Market Indices
Quotes & Charts

Global Indices
Arab Indices

US Markets Details

Commodoties

Oil & Energy

Currencies Cross Rates
Currencies Updates
Currency Converter

USA Stocks
Arab Stocks
 

Algeria 
Bahrain 
Egypt 
Iraq
Jordan 
Kuwait 
Lebanon
Morocco 
Oman 
Palestine
Qatar 
Saudi Arabia 
Syria
Tunisia 
UAE 
Yemen

Weather
Investment Game
Economic Calendar
Financial Glossary

My MENAFN
Portfolio Tracker

Voting

Financial Calculators

RSS Feeds [XML]

Corporate Monitor

Events

Real Estate
Submit Your Property

Arab Research
Buy a Research

Press Releases
Submit your PR

Join Newsletters


 
© 2000 menafn.com All Rights Reserved.  Terms of Service | Privacy Policy | Contact Us | Advertise | About MENAFN | Career Opportunities | Feedback | Help